External broker reports(aggregated public sources), Axis Direct

Axis Direct

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only.  Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

Global Health (Medanta) / Equity Bottom-Up

<ul><li>Steady Q2FY26 Performance: Medanta delivered a broadly in-line performance in Q2FY26, with revenue of Rs 1,099 Cr, up 15% YoY and 6.6% QoQ.</li><li>Growth was largely driven by an 8% YoY increase in occupied beds and ARPOB growth of 5.5%.</li><li>Reported occupancy stabilised at 64% despite new capacity additions in Ranchi and the commencement of operations at Noida. </li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Steady Q2FY26 Performance: Medanta delivered a broadly in-line performance in Q2FY26, with revenue of Rs 1,099 Cr, up 15% YoY and 6.6% QoQ.Growth was largely driven by an 8% YoY increase in occupied beds and ARPOB growth of 5.5%.Reported occupancy stabilised at 64% despite new capacity additions in Ranchi and the commencement of operations at Noida. Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Global Health Ltd - Strengthening Network with Noida Launch